Literature DB >> 20864620

Kraepelin was right: a latent class analysis of symptom dimensions in patients and controls.

Eske M Derks1, Judith Allardyce, Marco P Boks, Jeroen K Vermunt, Ron Hijman, Roel A Ophoff.   

Abstract

Phenotypic heterogeneity within patients and controls may explain why the genetic variants contributing to schizophrenia risk explain only a fraction of the heritability. The aim of this study is to investigate quantitative and qualitative differences in psychosis symptoms in a sample including psychosis patients, their relatives, and community controls. We combined factor analysis and latent class analysis to analyze variation in Comprehensive Assessment of Symptoms and History lifetime-rated symptoms in 4286 subjects. The Wechsler Adult Intelligence Scale-Intelligence Quotient (N = 2663) and the Camberwell Assessment of Need rating scale (N = 625) were assessed in a subsample. Variation in 5 continuous dimensions (disorganization, positive, negative, mania, and depression) was accounted for by the presence of 7 homogeneous classes (Kraepelinian schizophrenia, affective psychosis, manic-depression, deficit nonpsychosis, depression, healthy, and no symptoms). Eighty-five percent of the schizophrenia patients was assigned to the Kraepelinian schizophrenia class (characterized by high scores on the 5 dimensions, low IQ, and poor outcome) while 15% was assigned to the affective psychosis class (relatively low disorganization and negative scores, normal IQ, and good outcome). In bipolar patients (91% bipolar I), 41% was assigned to the Kraepelinian schizophrenia class, 44% to the affective psychosis class, and 10% to the manic-depression class. Latent class membership was associated with intelligence in psychosis patients and in their relatives but not in community controls. In conclusion, symptom heterogeneity is more pronounced in bipolar disorder compared with schizophrenia. Reducing phenotypic heterogeneity within psychosis patients and controls may facilitate etiological research.

Entities:  

Mesh:

Year:  2010        PMID: 20864620      PMCID: PMC3329975          DOI: 10.1093/schbul/sbq103

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  30 in total

1.  The nosology of psychotic disorders: a comparison among competing classification systems.

Authors:  Victor Peralta; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

2.  Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia.

Authors:  E Robins; S B Guze
Journal:  Am J Psychiatry       Date:  1970-01       Impact factor: 18.112

3.  Variability and stability in cognitive abilities are largely genetic later in life.

Authors:  R Plomin; N L Pedersen; P Lichtenstein; G E McClearn
Journal:  Behav Genet       Date:  1994-05       Impact factor: 2.805

4.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

Authors:  N C Andreasen; M Flaum; S Arndt
Journal:  Arch Gen Psychiatry       Date:  1992-08

Review 5.  The endophenotype concept in psychiatry: etymology and strategic intentions.

Authors:  Irving I Gottesman; Todd D Gould
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

6.  Characterising psychosis in the Australian National Survey of Mental Health and Wellbeing Study on Low Prevalence (psychotic) Disorders.

Authors:  S Rosenman; A Korten; J Medway; M Evans
Journal:  Aust N Z J Psychiatry       Date:  2000-10       Impact factor: 5.744

7.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.

Authors:  Patrick F Sullivan; Kenneth S Kendler; Michael C Neale
Journal:  Arch Gen Psychiatry       Date:  2003-12

8.  Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis.

Authors:  Margriet M Sitskoorn; André Aleman; Sjoerd J H Ebisch; Melanie C M Appels; René S Kahn
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

9.  Beyond symptom dimensions: schizophrenia risk factors for patient groups derived by latent class analysis.

Authors:  S J Leask; J K Vermunt; D J Done; T J Crow; M Blows; M P Boks
Journal:  Schizophr Res       Date:  2009-10-18       Impact factor: 4.939

10.  The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness.

Authors:  M Phelan; M Slade; G Thornicroft; G Dunn; F Holloway; T Wykes; G Strathdee; L Loftus; P McCrone; P Hayward
Journal:  Br J Psychiatry       Date:  1995-11       Impact factor: 9.319

View more
  13 in total

Review 1.  Categorical vs dimensional classifications of psychotic disorders.

Authors:  Melissa Potuzak; Caitlin Ravichandran; Kathryn E Lewandowski; Dost Ongür; Bruce M Cohen
Journal:  Compr Psychiatry       Date:  2012-06-07       Impact factor: 3.735

2.  Variation and validation: the example of schizophrenia.

Authors:  Kenneth F Schaffner
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

3.  Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning.

Authors:  Ganesh B Chand; Dominic B Dwyer; Guray Erus; Aristeidis Sotiras; Erdem Varol; Dhivya Srinivasan; Jimit Doshi; Raymond Pomponio; Alessandro Pigoni; Paola Dazzan; Rene S Kahn; Hugo G Schnack; Marcus V Zanetti; Eva Meisenzahl; Geraldo F Busatto; Benedicto Crespo-Facorro; Christos Pantelis; Stephen J Wood; Chuanjun Zhuo; Russell T Shinohara; Haochang Shou; Yong Fan; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite; Nikolaos Koutsouleris; Daniel H Wolf; Christos Davatzikos
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

4.  An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study.

Authors:  Dominic B Dwyer; Janos L Kalman; Monika Budde; Joseph Kambeitz; Anne Ruef; Linda A Antonucci; Lana Kambeitz-Ilankovic; Alkomiet Hasan; Ivan Kondofersky; Heike Anderson-Schmidt; Katrin Gade; Daniela Reich-Erkelenz; Kristina Adorjan; Fanny Senner; Sabrina Schaupp; Till F M Andlauer; Ashley L Comes; Eva C Schulte; Farah Klöhn-Saghatolislam; Anna Gryaznova; Maria Hake; Kim Bartholdi; Laura Flatau-Nagel; Markus Reitt; Silke Quast; Sophia Stegmaier; Milena Meyers; Barbara Emons; Ida Sybille Haußleiter; Georg Juckel; Vanessa Nieratschker; Udo Dannlowski; Tomoya Yoshida; Max Schmauß; Jörg Zimmermann; Jens Reimer; Jens Wiltfang; Eva Reininghaus; Ion-George Anghelescu; Volker Arolt; Bernhard T Baune; Carsten Konrad; Andreas Thiel; Andreas J Fallgatter; Christian Figge; Martin von Hagen; Manfred Koller; Fabian U Lang; Moritz E Wigand; Thomas Becker; Markus Jäger; Detlef E Dietrich; Harald Scherk; Carsten Spitzer; Here Folkerts; Stephanie H Witt; Franziska Degenhardt; Andreas J Forstner; Marcella Rietschel; Markus M Nöthen; Nikola Mueller; Sergi Papiol; Urs Heilbronner; Peter Falkai; Thomas G Schulze; Nikolaos Koutsouleris
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

5.  The identification of family subtype based on the assessment of subclinical levels of psychosis in relatives.

Authors:  Eske M Derks; Marco P M Boks; Jeroen K Vermunt
Journal:  BMC Psychiatry       Date:  2012-07-03       Impact factor: 3.630

Review 6.  Focus on psychosis.

Authors:  Wolfgang Gaebel; Jürgen Zielasek
Journal:  Dialogues Clin Neurosci       Date:  2015-03       Impact factor: 5.986

Review 7.  Gene x environment interactions in schizophrenia and bipolar disorder: evidence from neuroimaging.

Authors:  Pierre Alexis Geoffroy; Bruno Etain; Josselin Houenou
Journal:  Front Psychiatry       Date:  2013-10-14       Impact factor: 4.157

8.  Detecting Neuroimaging Biomarkers for Psychiatric Disorders: Sample Size Matters.

Authors:  Hugo G Schnack; René S Kahn
Journal:  Front Psychiatry       Date:  2016-03-31       Impact factor: 4.157

Review 9.  Factors of psychological distress: clinical value, measurement substance, and methodological artefacts.

Authors:  J R Böhnke; T J Croudace
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-02-15       Impact factor: 4.328

10.  Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis.

Authors:  Eske M Derks; Jacob A S Vorstman; Stephan Ripke; Rene S Kahn; Roel A Ophoff
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.